Results 1 to 8 of 8
Page 1 of 1
TypeTitleAuthor(s)YearViews
The effect of long-term nucleoside/tide analogue treatment on intrahepatic HBVDNA and covalently closed circular DNA in chronic hepatitis B patients
Proceedings/Conference:
Poster presentation at the International Liver Congress 2014 – 49th Annual meeting of the European Association for the Study of the Liver. Journal of hepatology : the journal of the European Association for the Study of the Liver
Wong, DKH; Lai, CL; Ip, PPC; Kopaniszen, M; Seto, WKW; Fung, JYY; Huang, FY; Wu, CH; Cheng, CTK; Ngai, WS; Yuen, RMF20141
 
THE EFFECT OF LONG-TERM NUCLEOSIDE/TIDE ANALOGUE TREATMENT ON INTRAHEPATIC HBVDNA AND COVALENTLY CLOSED CIRCULAR DNA IN CHRONIC HEPATITIS B PATIENTS
Proceedings/Conference:
International Liver Congress, European Association for the Study of the Liver
Wong, DKH; Lai, CL; Ip, PPC; Kopaniszen, M; Seto, WKW; Fung, JYY; Huang, FY; Wu, CH; Cheng, CTK; Ngai, WS; Yuen, RMF20137
 
Screening of occult HBV infection in blood donors in Hong Kong using nucleic acid testing
Proceedings/Conference:
Journal of Hepatology
Publisher:
Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
Wong, DKH; Lai, CL; Fung, JYY; Lee, CK; Lin, CK; Hung, IFN; But, D; Hsu, A; Chan, P; Cheung, TK; Fung, FKC; Yuen, JCH; Young, JLP; Ngai, WS; Yuen, RMF2008197
 
One-year treatment of entecavir results in reduction in intrahepatic covalently closed circular DNA level
Proceedings/Conference:
Hepatology
Publisher:
John Wiley & Sons, Inc. The Journal's web site is located at http://www.hepatology.org/
Wong, DKH; Yuen, RMF; Ngai, WS; Kwok, CL; Lai, CL2005101
 
Interim report on a phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in Chinese patients with chronic hepatitis B infection
Proceedings/Conference:
Journal of Hepatology
Publisher:
Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
Yuen, RMF; Kim, J; Wong, DKH; Ngai, WS; Yuen, JCH; Lai, CL2004157
 
Interim report on a phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in Chinese patients with chronic hepatitis B infection.
Proceedings/Conference:
39th Annual Meeting of the European Association for the Study of Liver, Berlin, Germany 14-18 Apr 2004 (published in J Hepatol)
Yuen, RMF; Kim, J; Wong, DKH; Ngai, WS; Yuen, JCH; Lai, CL2004147
 
Phase I/II double-blind, randomized, placebo-controlled study of the novel anti-HBV agent LB80380/ANA380 in patients with chronic HBV infection.
Proceedings/Conference:
55th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, USA 29 Oct-2 Nov 2004 (Published in Hepatology)
Yuen, RMF; Kim, J; Averett, D; Wong, DKH; Kim, CR; Kerr, B; Ngai, WS; Yuen, JCH; Lai, CL2004223
 
A phase I/IIa, double-blind, randomized, placebo-controlled trial of a novel antiviral agent, LB80380 in patients with chronic hepatitis B infection
Proceedings/Conference:
Antiviral Research
Publisher:
Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/antiviral
Yuen, RMF; Kim, J; Wong, DKH; Ngai, WS; Yuen, JCH; Lai, CL2003178
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download